402 related articles for article (PubMed ID: 22951441)
1. The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway.
Thurston G; Daly C
Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a006550. PubMed ID: 22951441
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.
Yuan HT; Khankin EV; Karumanchi SA; Parikh SM
Mol Cell Biol; 2009 Apr; 29(8):2011-22. PubMed ID: 19223473
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-2: development of inhibitors for cancer therapy.
Hu B; Cheng SY
Curr Oncol Rep; 2009 Mar; 11(2):111-6. PubMed ID: 19216842
[TBL] [Abstract][Full Text] [Related]
5. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of angiopoietin-2 and the Tie2 receptor but not angiopoietin-1 or the Tie1 receptor in a rat model of myocardial infarction.
Shyu KG; Liang YJ; Chang H; Wang BW; Leu JG; Kuan P
J Biomed Sci; 2004; 11(2):163-71. PubMed ID: 14966366
[TBL] [Abstract][Full Text] [Related]
7. Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling.
Mueller SB; Kontos CD
J Clin Invest; 2016 Sep; 126(9):3188-91. PubMed ID: 27548526
[TBL] [Abstract][Full Text] [Related]
8. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.
Akwii RG; Sajib MS; Zahra FT; Mikelis CM
Cells; 2019 May; 8(5):. PubMed ID: 31108880
[TBL] [Abstract][Full Text] [Related]
9. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
[TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of tie pathway in mouse lymphatic maturation and valve development.
Shen B; Shang Z; Wang B; Zhang L; Zhou F; Li T; Chu M; Jiang H; Wang Y; Qiao T; Zhang J; Sun W; Kong X; He Y
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1221-30. PubMed ID: 24764452
[TBL] [Abstract][Full Text] [Related]
11. The yin, the yang, and the angiopoietin-1.
Saharinen P; Alitalo K
J Clin Invest; 2011 Jun; 121(6):2157-9. PubMed ID: 21606600
[TBL] [Abstract][Full Text] [Related]
12. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ
Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279
[TBL] [Abstract][Full Text] [Related]
13. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
Pietilä R; Nätynki M; Tammela T; Kangas J; Pulkki KH; Limaye N; Vikkula M; Koh GY; Saharinen P; Alitalo K; Eklund L
J Cell Sci; 2012 May; 125(Pt 9):2212-23. PubMed ID: 22357955
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2-driven vascular remodeling in airway inflammation.
Tabruyn SP; Colton K; Morisada T; Fuxe J; Wiegand SJ; Thurston G; Coyle AJ; Connor J; McDonald DM
Am J Pathol; 2010 Dec; 177(6):3233-43. PubMed ID: 20952594
[TBL] [Abstract][Full Text] [Related]
15. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Falcón BL; Hashizume H; Koumoutsakos P; Chou J; Bready JV; Coxon A; Oliner JD; McDonald DM
Am J Pathol; 2009 Nov; 175(5):2159-70. PubMed ID: 19815705
[TBL] [Abstract][Full Text] [Related]
16. Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.
Song SH; Kim KL; Lee KA; Suh W
Biochem Biophys Res Commun; 2012 Mar; 419(2):281-6. PubMed ID: 22342979
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
Maisonpierre PC; Suri C; Jones PF; Bartunkova S; Wiegand SJ; Radziejewski C; Compton D; McClain J; Aldrich TH; Papadopoulos N; Daly TJ; Davis S; Sato TN; Yancopoulos GD
Science; 1997 Jul; 277(5322):55-60. PubMed ID: 9204896
[TBL] [Abstract][Full Text] [Related]
19. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
20. Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2.
Nguyen VP; Chen SH; Trinh J; Kim H; Coomber BL; Dumont DJ
BMC Cell Biol; 2007 Mar; 8():10. PubMed ID: 17341311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
